Interview with Karl Gisslander about the role and tasks of HIT in FAIRVASC project has been published.
You may also like
The second and third quarters of 2022 brought personnel changes in FAIRVASC. Kris McGlinn has left the FAIRVASC project. Thanks to his […]
The FAIRVASC consortium will meet for a Plenary meeting in the Conference Center at the Faculty of Medicine in Kraków, Poland on […]
Interview with Kris McGLinn about the role and tasks of QIT in FAIRVASC project has been published
Application for a clinical RMD research methodology was approved by the EULAR research Committee on the 12th of MARCH 2024, for a total […]